A randomized controlled trial comparing an intraoperative goal-directed strategy with routine clinical practice in patients undergoing peripheral arterial surgery

European Journal of Anaesthesiology

Volumn 27, Issue 9, 2010, Pages 788-793

  Van Der Linden, Philippe J ^a   Dierick, Ann ^a   Wilmin, Stéphan ^a   Bellens, Bernard ^a   De Hert, Stefan G ^a  

^a BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Anaesthetics; Goal directed therapy; Intravenous; Vascular surgery; Volatile

Indexed keywords

CISATRACURIUM; DOBUTAMINE; HEMOGLOBIN; PROPOFOL; SEVOFLURANE; SUFENTANIL;

ADULT; AGED; ANGINA PECTORIS; ARTERIAL BLOOD; ARTERY BYPASS; ARTICLE; CENTRAL VENOUS PRESSURE; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENERAL ANESTHESIA; HEART HEMODYNAMICS; HEART INDEX; HUMAN; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL; SURGICAL PATIENT; TISSUE OXYGENATION; URINARY TRACT INFECTION; VASCULAR SURGERY;

AGED; ANESTHESIA; ANESTHESIOLOGY; ANESTHETICS; ANESTHETICS, INHALATION; BLOOD VESSELS; CARDIOVASCULAR SURGICAL PROCEDURES; FEMALE; HEMODYNAMICS; HUMANS; MALE; METHYL ETHERS; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PROPOFOL;

EID: 77956859118     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0b013e32833cb2dd     Document Type: Article

References (39)

1. Schoemaker WC, Appel PL, Kram HB, et al. Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients. Chest 1988; 94:1176-1186.
2. Boyd O, Grounds RM, Bennett ED. A randomized clinical trial of the effect of deliberate perioperative increase of oxygen delivery on mortality in high- risk surgical patients. JAMA 1993; 270:2699-2707.
3. Wilson J, Woods I, Fawcett J, et al. Reducing the risk of major elective surgery: randomized controlled trial of preoperative optimisation of oxygen delivery. BMJ 1993; 18:1099-1103.
4. Holte K, Sharrock NE, Kehlet H. Pathophysiology and clinical implications of perioperative fluid excess. Br J Anaesth 2002; 89:622-632.
5. Grocott MP, Mythen MG, Gan TJ. Perioperative fluid management and clinical outcomes in adults. Anesth Analg 2005; 100:1093-1106.
6. Brandstrup B. Fluid therapy for the surgical patient. Best Pract Res Clin Anaesthesiol 2006; 20:265-283.
7. Chappell D, Jacob M, Hofman-Kiefer K, et al. A rational approach to perioperative fluid management. Anesthesiology 2008; 109:723-740.
8. Bundgaard-Nielsen M, Holte K, Secher NH, Kehlet H. Monitoring of perioperative fluid administration goal-directed therapy. Acta Anaesthesiol Scand 2007; 51:331-340.
9. Bundgaard-Nielsen M, Secher NH, Kehlet H. Liberal vs. restrictive perioperative fluid therapy: a critical assessment of the evidence. Acta Anaesthesiol Scand 2009; 53:843-851.
10. Bundgaard-Nielsen M, Ruhnau B, Secher NH, Kehlet H. Flow-related techniques for preoperative goal-directed fluid optimization. Br J Anaesth 2007; 98:38-44.
11. Button D, Weibel L, Reuthebruck O, et al. Clinical evaluation of the FloTrac/ Vigileo system and two established continuous cardiac output monitoring devices in patients undergoing cardiac surgery. Br J Anaesth 2007; 99:329-336.
12. de Waal EE, Rex S, Kruitwagen CL, et al. Validation of a new arterial pulse contour-based cardiac output device. Crit Care Med 2007; 35:1904-1905.
13. Mayer J, Boldt J, Schollhorn T, et al. Semi-invasive monitoring of cardiac output by a new device using arterial pressure waveform analysis: a comparison with intermittent pulmonary artery thermodilution in patients undergoing cardiac surgery. Br J Anaesth 2007; 98:176-182.
14. Opdam HI, Wan L, Bellomo R. A pilot assessment of the FloTrac cardiac output monitoring system. Int Care Med 2007; 33:344-349.
15. Zimmermann A, Kufner C, Hofbauer S, et al. The accuracy of the Vigileo- FloTrac continuous cardiac output monitor. J Cardiothorac Vasc Anesth 2008; 22:388-393.
16. Breukers RM, Sepehrkouy S, Spiegelenberg SR, Groeneveld AB. Cardiac output measured by a new arterial pressure waveform analysis method without calibration compared with thermodilution after cardiac surgery. J Cardiothorac Vasc Anesth 2007; 21 :632-635.
17. Lorsomradee S, Lorsomradee S, Cromheecke S, De Hert SG. Continuous cardiac output measurement: arterial pressure analysis versus thermodilution technique during cardiac surgery with cardiopulmonary bypass. Anaesthesia 2007; 62:979-983.
18. Lorsomradee S, Lorsomradee S, Cromheecke S, De Hert SG. Uncalibrated arterial pulse contour analysis versus continuous thermodilution technique: effects of alterations in arterial waveform. J Cardiothorac Vasc Anesth 2007; 21 :636-643.
19. Hofer CK, Senn A, Weibel L, Zollinger A. Assessment of stroke volume variation for prediction of fluid responsiveness using the modified Flotrac and PICCO plus system. Crit Care 2008; 12:R82.
20. Cannesson M, Musard H, Desebbe O, et al. The ability of stroke volume variation obtained with Vigileo/Flotrac system to monitor fluid responsiveness in mechanically ventilated patients. Anesth Analg 2009; 108:513-517.
21. Senn A, Button D, Zollinger A, Hofer CK. Assessment of cardiac output changes using modified FloTrac/Vigileo algorithm in cardiac surgery patients. Crit Care 2009; 13:R32.
22. De Hert SG. Perioperative assessment of volume status: measurement of preload is notmeasurementofpreload responsiveness. Eur J Anaesthesiol 2009; 26:269-271.
23. De Hert SG, Cromheecke S, ten Broecke PW, et al. Effects of propofol, desflurane, and sevoflurane on recovery of myocardial function after coronary surgery in elderly high-risk patients. Anesthesiology2003; 99:314-323.
24. De Hert SG, Van der Linden PJ, Cromheecke S, et al. Choice of primary anesthetic regimen can influence intensive care unit length of stay after coronary surgery with cardiopulmonary bypass. Anesthesiology2004; 101 :9-20.
25. Landoni G, Biondi-Zoccai GG, Zangrilla A, et al. Desflurane and sevoflurane in cardiac surgery: a meta-analysis of randomized clinical trials. J Cardiothorac Vasc Anesth 2007; 21 :502-511. (Pubitemid 47135634)
26. De Herr. SG, ten Broecke PW, Mertens E, et al. Sevoflurane but not propofol preserves myocardial function in coronary surgery patients. Anesthesiology 2002; 97:42-49.
27. Conzen PF, Fisher S, Detter C, Peter K. Sevoflurane provides greater protection of the myocardium than propofol in patients undergoing off- pump coronary artery bypass surgery. Anesthesiology 2003; 99:826-833.
28. De Hert SG, Van der Linden PJ, Cromheecke S, et al. Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration. Anesthesiology 2004; 101:299-310.
29. Bein B, Renner J, Caliebe D, et al. Sevoflurane but not propofol preserves myocardial function during minimally invasive direct coronary artery bypass surgery. Anesth Analg 2005; 100:610-616.
30. Guarracino F, Landoni G, Tritapepe L, et al. Myocardial damage prevented by volatile anesthetics: a multicenter randomised controlled study. J Cardiothorac Vasc Anesth 2006; 20:477-483.
31. Garcia C, Julier K, Bestmann L, et al. Preconditioning with sevoflurane decreases PECAM-1 expression and improves one-year cardiovascular outcome in coronary artery bypass graft surgery. Br J Anaesth 2005; 94:159-165.
32. Bignami E, Biondi-Zoccai G, Landoni G, et al. Volatile anesthetics reduce mortality in cardiac surgery. J Cardiothorac Vasc Anesth 2009; 23:594-599.
33. De Hert S, Vlasselaers D, Barbe R, et al. A comparison of volatile and non volatile agents for cardioprotection during on-pump coronary surgery. Anaesthesia 2009; 64:953-960.
34. Cromheecke S, Pepermans V, Hendrickx E, et al. Cardioprotective effects of sevoflurane in patients undergoing aortic valve repair with cardiopulmonary bypass. Anesth Analg 2006; 103:289-296.
35. Landoni G, Calabro MG, Marchetti C, et al. Desflurane versus propofol in patients undergoing mitral valve surgery. J Cardiothorac Vasc Anesth 2007; 21:672-677.
36. Landoni G, Zangrillo A, Fochi O, et al. Cardiac protection with volatile anesthetics in stenting procedures. J Cardiothorac Vasc Anesth 2008; 22:543-547.
37. De Hert SG, Longrois D, Yang H, Fleisher LA. Does the use of a volatile anesthetic regimen attenuate the incidence of cardiac events after vascular surgery? Acta Anaesth Belg 2008; 59:19-25.
38. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. J Am Coll Cardiol 2007; 50:1707-1732.
39. Poldermans D, Bax JJ, Boersma E, et al. Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Noncardiac Surgery of European Society of Cardiology (ESC); European Society of Anaesthesiology (ESA). Guidelines for preoperative cardiac risk assessment and perioperative cardiac management in non cardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Noncardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA). Eur J Anaesthesiol 2010; 27:92-137.